Ran Afik
6Patents
1h-index
9Co-inventors
40Inventor score
Filing activity: Sep 8, 2011 → May 3, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9421228B2 | Use of anti third party central memory T cells for anti-leukemia/lymphoma treatment | Chemistry; Metallurgy | 8 | Active |
| US9764008B2 | Variants of TACE pro-domain as TNF-A inhibitor and their medical use | Emerging Cross-Sectional Technologies | 1 | Active |
| US10933122B2 | Variants of TACE pro-domain as TNF-A inhibitor and their medical use | Emerging Cross-Sectional Technologies | 0 | Active |
| US11324777B2 | Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment | Chemistry; Metallurgy | 0 | Active |
| US12133866B2 | Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment | Chemistry; Metallurgy | 0 | Active |
| US10426821B2 | Variants of TACE pro-domain as TNF-A inhibitor and their medical use | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.